The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery

NCT ID: NCT07056049

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-13

Study Completion Date

2027-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intervention abstract

Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life.

Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established.

Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery.

Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks. They will be monitored pre and post training, and 6 months post-stroke. Outcome measures will include clinical, kinematic and adherence measures (see complete list in the protocol).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Hemiplegia and Hemiparesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

The intervention group will be compared to a matched historical cohort, that will be added to in parallel during recruitment.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

This group will be provided with additional rehab time during the sub actue phase.

Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks.

The program will be tailored to their impairment level, and will be added to the usual treatment given during hospitalization.

Group Type EXPERIMENTAL

High dosage, high intensity motor rehabilitation

Intervention Type BEHAVIORAL

Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks.

Matched group from an ongoing project with identical criteria.

This group is comprised of patients with similar characteristics and the intervention group will be compared to this group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High dosage, high intensity motor rehabilitation

Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI
* First-ever stroke or previous stroke with no upper extremity weakness
* 1 week ≤ Time after stroke onset ≤ 6 weeks
* Active shoulder flexion of at least 20◦ and partial wrist and/or finger active movement
* Ability to provide inform consent

Exclusion Criteria

* A painful shoulder limiting an active forward reach
* Severe spasticity or non-neural loss of range of motion
* Cognitive or communication impairments as determined by the clinical team Unstable medical conditions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ben-Gurion University of the Negev

OTHER

Sponsor Role collaborator

Adi Negev-Nahalat Eran

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lior Shmuelof, Prof.

Role: PRINCIPAL_INVESTIGATOR

Ben-Gurion University of the Negev

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adi Negev-Nahalat Eran

Ofakim, , Israel

Site Status NOT_YET_RECRUITING

Adi Negev-Nahalat Eran

Ofakim, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gil Meir

Role: CONTACT

+972 0548340307

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lior Shmuelof, Prof.

Role: primary

+972 0547510795

Gil Meir

Role: primary

+9720548340307

References

Explore related publications, articles, or registry entries linked to this study.

Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010 Oct;41(10):2402-48. doi: 10.1161/STR.0b013e3181e7512b. Epub 2010 Sep 2. No abstract available.

Reference Type BACKGROUND
PMID: 20813995 (View on PubMed)

Kwakkel G, Kollen BJ, van der Grond J, Prevo AJ. Probability of regaining dexterity in the flaccid upper limb: impact of severity of paresis and time since onset in acute stroke. Stroke. 2003 Sep;34(9):2181-6. doi: 10.1161/01.STR.0000087172.16305.CD. Epub 2003 Aug 7.

Reference Type BACKGROUND
PMID: 12907818 (View on PubMed)

Buch ER, Rizk S, Nicolo P, Cohen LG, Schnider A, Guggisberg AG. Predicting motor improvement after stroke with clinical assessment and diffusion tensor imaging. Neurology. 2016 May 17;86(20):1924-5. doi: 10.1212/WNL.0000000000002675. Epub 2016 Apr 29. No abstract available.

Reference Type BACKGROUND
PMID: 27164664 (View on PubMed)

Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci. 2004 Feb 4;24(5):1245-54. doi: 10.1523/JNEUROSCI.3834-03.2004.

Reference Type BACKGROUND
PMID: 14762143 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NGV-24-0006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Strength Training and Stroke
NCT00629005 COMPLETED PHASE1/PHASE2